Logo Image
News
OncClubAll Oncology NewsClinical Trials in Focus
Media
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid ReadoutsShorts
Conferences
Conference CoverageConference Listing
Events
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
More
Partners
Publications
All PublicationsSupplements
Resources
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker Consortium

Subscribe

  • News
  • Media
  • Conferences
  • Events
  • Partners
  • Publications
  • Resources
  • Biomarker Consortium
  • Subscribe
  • AI for Oncology
  • Biosimilars
  • Brain Cancer
  • Breast Cancer
    • HER2+ Breast Cancer
  • CAR T-Cell Therapy
  • Disparities in Cancer Care
  • Gastrointestinal Cancer
    • Pancreatic Cancer
    • Hepatocellular Carcinoma
    • Gastric Cancer
    • Colorectal Cancer
  • Genitourinary Cancers
    • Urothelial Cancer
    • Prostate Cancer
  • Global Oncology
  • Graft-vs-Host Disease
  • Gynecologic Oncology
    • Ovarian Cancer
  • Head & Neck Cancers
  • Hematologic Oncology
    • Chronic Lymphocytic Leukemia
    • Non-Hodgkin Lymphoma
    • Mantle Cell Lymphoma
    • Multiple Myeloma
    • Myeloproliferative Neoplasms
  • Immuno-Oncology
  • Lung Cancer
  • Melanoma & Skin Cancer
  • Oncology Business Management
  • Pediatric Oncology
  • Precision Medicine in Oncology®
  • Sarcomas
  • Supportive Care
Spotlight -
The OncLive Insider app is live!|
CME Opportunities
Advertisement

Early Diagnosis of Myeloma: Guideline Compliant Testing

EP. 1: Advances in Multiple Myeloma Diagnostic Work-up

March 19th 2020

EP. 2: Prevalence and Relapse of Multiple Myeloma and MGUS

March 19th 2020

EP. 3: The Clinical Significance of MGUS

March 19th 2020

EP. 4: MGUS and Multiple Myeloma (MM) Diagnostic Criteria

March 19th 2020

EP. 5: The Importance of Early Diagnosis: Multiple Myeloma, MGUS & AL Amyloidosis

March 19th 2020

EP. 6: MGUS Management Guidelines for Practicing Internists

March 19th 2020

EP. 7: Clinical Significance of Available FLC Assays

March 19th 2020

EP. 8: MGUS Progression Risk: Immune Marker Alterations & FLC

March 19th 2020

EP. 9: MGUS Follow-Up Recommendations

March 19th 2020

EP. 10: The Role of Genetic Testing and Targeted Therapy

March 19th 2020

EP. 11: The Future of Multiple Myeloma Management

March 19th 2020
Advertisement
Advertisement

Trending on OncLive

1

HERIZON-GEA-01 PD-L1 Subgroup Data Support Zanidatamab Combo as a New Frontline SOC in HER2+ GEA

2

Selinexor Plus Ruxolitinib Yields Superior Spleen Responses, OS Signal in JAK Inhibitor–Naïve Myelofibrosis

3

Antibody-Drug Conjugates in Lung Cancer: The Tip of the Iceberg

4

TALAPRO-3 Shows Talazoparib Plus Enzalutamide Improves rPFS in HRR-Altered mCSPC

5

Dr Eads on Early Data for CDH17-Directed CAR T-Cell Therapy in R/R GI Cancers

  • Advertise
  • About OncLive
  • Editorial Board
  • MJH Life Sciences brands
  • Contact Us
  • Privacy
  • Terms & Conditions
  • Do Not Sell My Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo
Download on Apple
Download on Google Play

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us